Home » Topics » Regulatory » Patents

Patents
RSS

Qilu Regor Therapeutics presents new CDK inhibitors

Nov. 30, 2020

New CD134 agonists identified at Bicycle Therapeutics

Nov. 30, 2020

Janssen discovers anti-HBV compounds

Nov. 30, 2020

University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1

Nov. 30, 2020

Abmax Biopharmaceuticals TNF-alpha-targeting antibodies

Nov. 27, 2020

Chaser Therapeutics identifies new USP28 and USP25 inhibitors

Nov. 27, 2020

Idorsia Pharmaceuticals synthesizes new PDK1 inhibitors

Nov. 27, 2020

TYK Medicines divulges protein kinase inhibitors

Nov. 27, 2020

Genfleet Therapeutics describes new RIPK1 inhibitors

Nov. 27, 2020

Bluebird bio divulges non-natural T cells for cancer

Nov. 26, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...